title: [Serious organ damage and intractable clinical conditions in rheumatic and connective tissue disease--progress in pathophysiology and treatment. Topics: I. Damage to important organs whose early treatment makes a big difference; 9. Rheumatoid arthritis: the progress of pathology and therapeutic strategy].
authors.affiliation: Department of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences, Japan.
authors.forename: Mami
authors.initials: M
authors.lastname: Tamai
authors.affiliation: Department of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences, Japan.
authors.forename: Atsushi
authors.initials: A
authors.lastname: Kawakami
mesh_terms: D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000175:diagnosis / Q000209:etiology / Q000473:pathology / Q000628:therapy*; D001323:Autoantibodies; D020022:Genetic Predisposition to Disease / Q000235:genetics; D006684:HLA-DR Antigens; D006801:Humans; D008279:Magnetic Resonance Imaging; D058990:Molecular Targeted Therapy; D020127:Recovery of Function; D012074:Remission Induction; D014463:Ultrasonography
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D000911:Antibodies, Monoclonal; D001323:Autoantibodies; D006684:HLA-DR Antigens